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Oral cancer staging established by 
magnetic resonance imaging
Abstract: The aim of this study was to compare clinical staging and 
magnetic resonance imaging (MRI) staging for oral cancer, and to assess 
inter-observer agreement between oral and medical radiologists. A total 
of 10 patients diagnosed with oral cancer were assessed before treatment. 
A head and neck surgeon performed clinical TNM staging. Two medical 
radiologists and two oral radiologists performed a new staging assess-
ment by interpreting MRI scans, without prior knowledge of the clinical 
staging. They evaluated the extent of the primary tumor (T), metastasis 
to regional lymph nodes (N) and grouping by stages. The data were ana-
lyzed using the Kappa Index. There was significant agreement (p < 0.05) 
between the clinical and MRI staging assessments made by one oral radi-
ologist for N stage, and between those made by one medical radiologist 
for the T and N stages and for the grouping by stages. In the MRI assess-
ment, there was significant agreement among all four observers for both 
T stage and grouping by stages. For the N stage, there was no signifi-
cant agreement between one oral radiologist and one medical radiologist 
or between both medical radiologists. There was significant agreement 
among the remaining radiologists. There was no agreement between the 
clinical and MRI staging. These results indicate the importance of using 
MRI for the diagnosis of oral cancer. Training initiatives and calibration 
of medical and oral radiologists should be promoted to provide an im-
proved multidisciplinary approach to oral cancer.
Descriptors: Magnetic Resonance Imaging; Mouth Neoplasms; Head 
and Neck Neoplasms.
Introduction
The prognosis of carcinoma of the maxillofacial region is influenced 
by a variety of factors, such as the degree of cellular differentiation, size, 
location, presence of infiltration into the bone tissue, immune response, 
age, gender, patient’s socio-economic status and the presence of cervical 
lymph node metastasis, the latter being considered the most significant 
factor when determining the prognosis.1-3 Incidence and mortality rates 
vary from one country to another and even within countries, because 
of differences in customs, especially tobacco use and alcohol consump-
tion, environmental factors and the quality of medical care.4 Oral cancer 
is diagnosed after clinical examination, biopsy and anatomic pathology 
examination of the lesion have been carried out. After the diagnosis has 
been established, an assessment is then needed of the extent and spread 
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of the disease. Staging, which can be defined as the 
quantification of the clinical parameters of the dis-
ease, helps in making therapeutic decisions and in 
establishing a prognosis for the patient.1-3,5,6 The 
TNM system classifies the anatomical extent of the 
disease in any part of the body, by using clinical ob-
servation and histological and surgical complemen-
tation, or diagnostic imaging methods.
The choice of appropriate treatment for patients 
with oral cancer depends largely on accurate pre-
treatment staging and, above all, on the detection 
of cervical lymph node involvement.2,3,7 In cases of 
clinically negative necks (N0), the clinical examina-
tion may present up to a 40% failure rate in detect-
ing lymph node metastases.2,3,8,9 A combination of 
clinical and imaging examinations is essential for 
detecting metastatic lymph nodes and establishing 
the prognosis.10,11 Of the imaging modalities, com-
puted tomography (CT) and magnetic resonance im-
aging (MRI) seem to be the most appropriate for the 
pre-therapeutic staging of head and neck tumors, 
because they provide information on the extent of 
the lesion, infiltration of large vessels and metasta-
ses in lymph nodes.3,12-14
The major advantage of MRI is that it provides 
excellent soft tissue detail visualization and does not 
involve any biological risks for the patient. Research 
that can facilitate or provide further information on 
staging means that patients will be adequately treat-
ed and consequently have a greater chance of being 
cured. The aim of this study was to compare the 
staging (TNM classification) established by clinical 
and MRI examinations for oral cancer, and to as-
sess inter-observer agreement between medical and 
oral radiologists when analyzing MRI scans.
Methodology
Sample
A total of 10 patients seen at the Oral Cancer 
Center at the Division of Dentistry in the University 
Hospital of Brasília (UnB), from October 2005 to 
December 2008, with a histologically proven diag-
nosis of oral squamous cell carcinoma were exam-
ined and submitted to MRI before treatment. This 
study was approved by the Ethics Committee at 
UnB (no. 025/2007) and informed consent was ob-
tained from all patients. Table 1 presents the clinical 
characteristics of the patients.
After clinical examination and biopsies, the 
patients were referred to a head and neck surgeon 
to establish their clinical TNM stage and undergo 
treatment. They concomitantly underwent the CT 
and MRI examinations. The CT data were pub-
lished in a previous study.15 Four observers inter-
preted the MRI scans. Observers 1 and 2 were den-
tal specialists holding a Master’s in oral radiology, 
and Observers 3 and 4 were medical radiologists. 
These four radiologists established staging based on 
the MRI scans without any prior knowledge of the 










1 Female 50 No No Gum – R T2N0M0 II
2 Male 72 Yes Yes Base of tongue – L T3N0M0 III
3 Male 55 Yes Yes Retromolar region – L T2N1M0 III
4 Male 51 Yes Yes Floor of mouth – R/L T4N2M0 IVA
5 Male 41 Yes Yes Tongue – R/L T4N2M0 IVA
6 Male 69 Yes Yes Floor of mouth – R/L T4N0M0 IVA
7 Female 48 Yes Yes Side of tongue – R T1N0M0 I
8 Female 50 Yes No Base of tongue – R T1N0M0 I
9 Male 62 Yes Yes Side of tongue – R T1N0M0 I
10 Male 54 Yes Yes Floor of mouth – R T2N2M0 IVA
R = right; L = left.
Table 1 - Demographic and 
clinical data of patients in the study 
sample.
Oral cancer staging established by magnetic resonance imaging
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neck surgeon.
Three parameters were evaluated, namely, the 
extent of the primary tumor (T), the presence/ab-
sence and extent of metastasis in regional lymph 
nodes (N) and the grouping by stages. The criteria 
established by Prehn et al.16 were used to ascertain 
which cervical lymph nodes were affected when cer-
vical metastasis occurred.
Magnetic resonance imaging and 
interpretation
MRI was performed with a Signa Excite 1.5 
high-field device (1.5 Tesla) (General Electric 
Healthcare Inc., Milwaukee, USA), following the 
protocol of the institution. Images of the head and 
neck region were taken to assess cervical lymph node 
involvement. The examinations included T1 (TR/
TE, 350/13.1 ms; FOV 24 × 24 mm; slice width/gap, 
3,5/1 mm; slice number, 30), T1 with contrast (TR/
TE, 300/4.8 ms; FOV 24 × 24 mm; slice width/gap, 
3,5/1 mm; slice number, 30) and T2-weighted (TR/
TE, 4600/99.4 ms; FOV 26 × 26 mm; slice width/
gap, 5/1 mm; slice number, 30) sequences on three 
anatomical planes (axial, coronal and sagittal). A 
gadolinium-based contrast agent (Gd/DTPA - Dieth-
ylene Triamine Pentaacetic Acid) was used.
The MRI scans were interpreted on a Toshiba 
Satellite A65 laptop computer (Toshiba America 
Information Systems, Inc., Irvine, USA), with a 14-
inch screen. Printed films were not used. The eFilm 
2.0 program (Merge Healthcare Inc., Chicago, 
USA), which provides a DICOM (Digital Imaging 
Communication in Medicine) reading, was used 
to visualize and analyze the images. The MR im-
ages were considered the standard parameter in this 
study.
Statistical analysis
A descriptive analysis was performed using 
mean, median, standard deviation, and both maxi-
mum and minimum values. The SPSS for Windows 
program, version 13.0 (SPSS Inc., Chicago, USA) 
was used for all the statistical tests. Inter-observer 
agreement as regards MRI staging, T stage, N stage 
and grouping by stages was analyzed using Cohen’s 
kappa index. A statistical significance level of 95% 
(p value < 0.05) and a 5% error level were consid-
ered for the analyses. Interpretation criteria of the 
kappa index recommended by Landis and Koch17 
were used to analyze the results.
Results
Table 2 shows that agreement for the T stage was 
excellent (k = 0.85) between Observers 1 and 2 (oral 
radiologists) and moderate (k = 0.47) between Ob-
servers 3 and 4 (medical radiologists). 
All four observers presented different results for 
the T stage using the clinical and MRI examinations. 
The highest rate of agreement (k = 0.46 = moderate) 
was presented by Observer 4.
Table 3 shows that agreement for the N stage 
was substantial (k = 0.69) between Observers 1 and 
2 (oral radiologists) and considerable (k = 0.38) be-
tween Observers 3 and 4 (medical radiologists).
All four observers presented different results for 
the N Stage using the clinical and MRI examina-
tions.
Table 4 shows that the agreement for grouping by 

























k = kappa value; *p < 0.05 = statistically significant agreement; Obs. = observer; 1 and 2 = oral radiolo-
gists; 3 and 4 = medical radiologists.
Table 2 - Inter-observer and 
clinical and MRI examination 
agreement for T Stage.
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stages was substantial (k = 0.72) between Observers 
1 and 2 (oral radiologists) and moderate (k = 0.44) 
between Observers 3 and 4 (medical radiologists). 
All four observers presented different results 
for the grouping by stages using the clinical and 
MRI examinations. The highest rate of agreement 
(k = 0.44 = moderate) was presented by Observer 4.
Table 5 shows that there was significant agree-
ment (p < 0.05) between the clinical and MRI stag-
ing assessments made by one oral radiologist (Ob-
server 2) for N stage, and significant agreement 
between those made by one medical radiologist 
(Observer 4) for T and N stages and for grouping 
by stages.
As to MRI staging, there was significant agree-
ment (p < 0.05) among all four observers for T stage 
and for grouping by stages, and there was no sig-
nificant agreement between Observers 1 and 4, or 
between 3 and 4, for N stage. In all other compari-
sons, there was significant agreement (p < 0.05) for 
N stage (Table 6).
Discussion
The results of the present study contribute to rec-
ognizing the importance of MRI examination in es-
tablishing the staging of oral cancer.
Carcinoma lesions in the oral cavity are very ag-
gressive and usually infiltrate the surrounding tissue 
and lymph vessels, producing metastasis in the cer-
vical region.2,18
CT and MRI examinations are the most signifi-
cant methods of diagnostic imaging in the preopera-
tive staging of head and neck tumors, because they 
provide information on the extent of the lesion, in-
filtration of large vessels and lymph node metastasis, 
thereby facilitating treatment planning and progno-
sis.12-14,19 During the preoperative phase of a patient’s 
squamous cell carcinoma, CT scans are essential for 
evaluating the primary lesion and the possibility of 
bone invasion, and especially for defining involve-
ment in cervical lymph node chains.12-14,19 In the 
preoperative treatment of oral cancer, it has been 
shown that MRI is better for evaluating soft tissue, 
bone marrow involvement and perineural invasion, 





















 (p = 0.014)*
Obs. 3
k = 0.38
 (p = 0.075)
k = kappa value; *p < 0.05 = statistically significant agreement; Obs. = observer; 1 and 2 = oral radiolo-
gists; 3 and 4 = medical radiologists.
Table 3 - Inter-observer and 
clinical and MRI examination 
agreement for N Stage.


























k = kappa value; *p < 0.05 = statistically significant agreement; Obs. = observer; 1 and 2 = oral radiolo-
gists; 3 and 4 = medical radiologists.
Table 4 - Inter-observer and 
clinical and MRI examination 
agreement for Group Staging.
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and has been particularly decisive in the diagnosis 
of small lesions.7,20,21
The discrepancies found in the comparisons be-
tween the staging established by clinical and MRI 
examinations demonstrate the importance of this 
study. A clinical staging assessment lower than the 
real staging could result in ineffective treatment and/
or increase the possibility of recurrence in a partic-
ular case, whereas a higher clinical staging assess-
ment could lead to more radical treatment, thereby 
increasing treatment aftereffects. The related litera-
ture states that appropriate staging of a lesion is es-
sential for decision-making during surgical and/or 
radiotherapy planning, for predicting the prognosis 
and for deciding how to carry out patient follow-up 
to guarantee greater life expectancy and cure.1,2,7
Different results were found between the clini-
cal and MRI examinations for T staging. If a clini-
cal staging assessment establishes a primary tumor 
as smaller than it really is, this could result in in-
effective surgical margins and in an incomplete re-
moval of the lesion.7 Figures 1 through 3 show case 
number 8 clinically staged as T1, in which the MRI 
shows the primary tumor measuring 3.4  cm (T2). 
Surgical and anatomic pathology confirmation 
would be necessary to determine the actual size of 
the primary tumor.
Agreement among all four observers was sig-
nificant for MRI T staging. This agreement shows 
that MR images provide greater interpretation stan-
dardization. Calibration of the observers may have 
been decisive in achieving the agreement levels and 
should be used in joint training programs that pre-
pare medical and oral radiologists to diagnose oral 
cancer at reference centers providing multidisci-
plinary care.15
There was substantial and significant agreement 
between the clinical and MRI staging performed by 
Observers 2 and 4 for N stage. Nevertheless, case 
number 3, clinically staged as N1, was staged as N0 
by two observers (1 and 3) in the MRI examination. 
A higher clinical staging assessment, establishing a 
false-positive for regional metastasis, may lead to 
more radical treatment and increase morbidity. Ac-
cording to Malard et al.10 and Scully and Bagan,11 a 
combination of both clinical and imaging examina-
tions is essential for the detection of metastatic cer-
vical lymph nodes, and could improve staging and 
prognosis determination.
Agreement between Observers 1 and 2, 1 and 3, 
2 and 3, and 2 and 4 in the MRI staging was sig-
nificant, indicating that the pre-established criteria 
and image interpretation guide could also have been 
crucial for the level of agreement achieved for the N 
stage.
Different results were observed for the clinical 
Inter-observer agreement T stage N stage Grouping
oral radiologist 1 × oral radiologist 2 k = 0.85* k = 0.69* k = 0.72*
oral radiologist 1 × medical radiologist 3 k = 0.42* k = 0.84* k = 0.72*
oral radiologist 1 × medical radiologist 4 k = 0.58* k = 0.24 k = 0.44*
oral radiologist 2 × medical radiologist 3 k = 0.57* k = 0.84* k = 0.58*
oral radiologist 2 × medical radiologist 4 k = 0.73* k = 0.55* k = 0.72*
medical radiologist 3 × medical radiologist 4 k = 0.47* k = 0.38 k = 0.44*
k = kappa value; *p < 0.05 = statistically significant agreement.
Table 6 - Inter-observer 
agreement for MRI staging.
Agreement between clinical and MRI staging T stage  N stage Grouping
clinical × oral radiologist (Obs. 1) k = 0.29 k = 0.35 k = 0.31
clinical × oral radiologist (Obs. 2) k = 0.31 k = 0.68* k = 0.31
clinical × medical radiologist (Obs. 3) k = 0.17 k = 0.47 k = 0.13
clinical × medical radiologist (Obs. 4) k = 0.46* k = 0.69* k = 0.44*
k = kappa value; *p < 0.05 = statistically significant agreement; Obs. = observer.
Table 5 - Agreement between 
clinical and MRI staging 
assessments for all four observers.
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and MRI staging, and agreement was significant 
only for Observer 4. Among these results, three cases 
were staged as belonging to the IVA grouping, which 
represents lesions which are larger and at a more ad-
vanced stage, thereby facilitating diagnosis.15 This 
confirms the greater importance of the MRI exami-
nation for smaller lesions. The definition of grouping 
by stages is critical in determining the patient’s treat-
ment plan, prognosis and survival span.
Agreement among all four observers for stage 
grouping using MRI was significant, and greater be-
tween the oral radiologists. Based on these results 
and on literature data, it could be stated that clini-
cal examination, anatomic pathology testing and 
diagnostic imaging modalities (which could include 
CT and MRI) are necessary to establish the staging 
of patients with oral cancer. According to Weber et 
al.13 and Scully and Bagan,22 CT and MRI examina-
tions seem to be the most important diagnostic tools 
when establishing pre-therapeutic staging of head 
and neck tumors. CT is essential, insofar as it pro-
vides a better evaluation of cervical lymph node in-
volvement and invasion of bone cortices adjacent to 
the primary tumor area. The MRI examination pro-
vides a better evaluation of the soft tissues affected 
by the lesion and allows a more thorough evaluation 
of small tumors. This examination should be part of 
the treatment protocol of patients with oral cancer, 
depending on its availability, accessibility and the 
possibility of carrying out the examination. Accord-
ing to Warnakulasuriya,4 improvement in the qual-
ity of healthcare helps to reduce mortality rates.
Figure 2 - MRI axial slice, T1-weighted, with contrast, show-
ing a tumor of hyper-signal intensity (enhanced with contrast) 
at the base of the tongue (arrowhead), on the right side.
Figure 3 - MRI coronal slice, T2-weighted, showing a tumor 
of isosignal intensity at the base of the tongue (arrowhead), 
on the right side.
Figure 1 - MRI axial slice, T1-weighted, without contrast, 
showing a tumor of isosignal intensity at the base of the 
tongue (arrowhead), on the right side, measuring approxi-
mately 3.4 cm.
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While the results would indicate the importance 
of using MRI in the diagnosis of oral cancer, there 
is also a very obvious need for a combination of re-
search and surgical and pathological information 
to identify sources of error in pretreatment staging. 
Joint training initiatives and calibration of medical 
and oral radiologists should be promoted to provide 
an improved multidisciplinary approach to oral can-
cer.
Conclusion
There was no agreement between the staging es-
tablished by clinical and MRI examinations for oral 
cancer. MRI examination is useful to provide a bet-
ter assessment of TNM staging, and the examina-
tions should be analyzed by different professionals 
(physicians and dentists) in a multidisciplinary ap-
proach.
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